First patient dosed in Compass Therapeutics’ Phase Ib solid tumour trial

CTX-471 attaches to the CD137 receptor’s membrane proximal epitope, leading to improved activation of T-Cells and NK Cells.

IGC starts clinical trial of drug candidate to treat agitation in dementia

The objective of the trial is to establish IGC-AD1’s efficacy in helping dementia patients reduce neuropsychiatric symptoms.

Curebase and Redenlab to partner for data capture capabilities expansion

The analytical component provides researchers with a comprehensive monitoring approach in trials.

How to cut drug supply costs with seamless forecasting and IRT systems

Cut drug wastage, reduce risk, and optimise supply with advanced, integrated technologies designed to deliver increased visibility, flexibility and accuracy.

Petition to update US alcohol warning label could prevent many cancer cases

Individuals who are more prone to alcoholism are at an increased risk of breast and colorectal cancers.